Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858

Vicki Morrison

doi:10.1080/10428190600648713

Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858

Vicki Morrison

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	780-782
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	47
Issue number	5
DOIs	https://doi.org/10.1080/10428190600648713
State	Published - May 2006
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1080/10428190600648713

OpenUrl availability

Full text

Cite this

Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858. / Morrison, Vicki.
In: Leukemia and Lymphoma, Vol. 47, No. 5, 05.2006, p. 780-782.

Research output: Contribution to journal › Comment/debate › peer-review

@article{131b649acf294f87a277fe6c94f14b39,

title = "Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858",

author = "Vicki Morrison",

year = "2006",

month = may,

doi = "10.1080/10428190600648713",

language = "English (US)",

volume = "47",

pages = "780--782",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "5",

}

TY - JOUR

T1 - Myeloid growth factors

T2 - To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858

AU - Morrison, Vicki

PY - 2006/5

Y1 - 2006/5

UR - http://www.scopus.com/inward/record.url?scp=33744923717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744923717&partnerID=8YFLogxK

U2 - 10.1080/10428190600648713

DO - 10.1080/10428190600648713

M3 - Comment/debate

C2 - 16753858

AN - SCOPUS:33744923717

SN - 1042-8194

VL - 47

SP - 780

EP - 782

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 5

ER -

Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this